Clinical Trial Update: Safety Study of BMS-823778 in Subjects With Hypercholesterolemia [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 safety study of BMS-823778 in adults with hypercholesterolemia (dyslipidemia).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia

Drugs mentioned

• BMS-823778

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Dyslipidemia | Phase 2 | Status: COMPLETED